Drugs Made In America Acquisition Corp.
DMAA
$10.27
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | 82.43% | 548.20% | |||
| Total Depreciation and Amortization | -- | -- | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -63.08% | -4,818.04% | |||
| Change in Net Operating Assets | 342.95% | -111.91% | |||
| Cash from Operations | 57.52% | -103.90% | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 100.00% | -- | |||
| Cash from Investing | 100.00% | -- | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | 100.00% | 12.53% | |||
| Issuance of Common Stock | -99.95% | 929,090.40% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -100.00% | 101.23% | |||
| Cash from Financing | -99.95% | 187,420.91% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 75.00% | -300.00% | |||